The PRO-ACTIVE randomized clinical trial offers 3 swallowing therapies to Head and Neck
Cancer (HNC) patients during radiotherapy (RT) namely: reactive, proactive low-(“EAT-RT” …

The PRO-ACTIVE randomized clinical trial offers 3 swallowing therapies to Head and Neck
Cancer (HNC) patients during radiotherapy namely: reactive, proactive low-(“EAT-RT” only) …

Introduction Dysphagia emerges as a frequent, persistent and enduring aftermath in
individuals undergoing radiotherapy for head and neck cancer (HNC). Timely intervention …

Introduction Dysphagia emerges as a frequent, persistent and enduring aftermath in
individuals undergoing radiotherapy for head and neck cancer (HNC). Timely intervention …

Background Head and neck cancer (HNC) is the sixth most common cancer worldwide, and
the functional, psychological and social consequences of HNC cancer and its treatment can …

We undertook a service evaluation to establish how oropharyngeal dysphagia is managed
in head and neck cancer patients receiving radiotherapy in the United Kingdom. A web …

Purpose The study aims to describe patients' experiences of swallowing difficulties following
(chemo) radiotherapy for head and neck cancer and to explore any changes over time …

Emerging research suggests that preventative swallowing rehabilitation, undertaken before
or during (chemo) radiotherapy ([C] RT), can significantly improve early swallowing …

Intensive, prophylactic swallowing therapy programs have been developed to improve
dysphagia outcomes for patients with head/neck cancer (HNC) receiving (chemo) …

Many head and neck cancer (HNC) survivors experience reduced quality of life due to
radiotherapy (RT)-related dysphagia. The aim of this prospective randomized trial was to …